AC
IDXX icon

ASB Consultores’s Idexx Laboratories IDXX Stock Holding History

ASB Consultores’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-465
Closed -$251K – 243
2024
Q1 		$251K Buy
+465
New +$254K 0.06% 248
2022
Q2 		– Sell
-532
Closed -$291K – 201
2022
Q1 		$291K Buy
532
+92
+21% +$48.4K 0.12% 155
2021
Q4 		$290K Buy
+440
New +$276K 0.14% 157

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ASB Consultores's IDXX Position: Q2 2024 in Review

ASB Consultores sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 465 shares — an estimated $251K sold.

ASB Consultores first reported a position in IDXX in Q4 2021 and held it in 3 quarters. The position peaked at $291K in Q1 2022. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • ASB Consultores reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • ASB Consultores sold 465 Idexx Laboratories shares in Q2 2024, an estimated $251K.
  • ASB Consultores first reported a position in Idexx Laboratories in Q4 2021 and held it in 3 quarters.
  • ASB Consultores's Idexx Laboratories position peaked at $291K in Q1 2022.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.